LifeMD (LFMD) Stock Price

LifeMD Price

NASDAQ·CLOSED
4.15USD-0.35 (-8.09 %)
Market closed

Revenue has compounded at 43.9% per year over the past 14 years to 212.45 M USD. LifeMD's net margin stands at -10.3%, up from -170.0% several years earlier. Analysts set a median price target of 8.67 USD, implying 108.9% above the current price. Of 14 analysts, 12 rate the stock a buy — an overall Buy consensus. The stock trades about 57% above its 52-week low.

LifeMD stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of LifeMD over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how LifeMD stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing LifeMD's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

LifeMD Stock Price History
DateLifeMD Price
7/17/20264.15 USD
7/16/20264.50 USD
7/15/20264.53 USD
7/14/20264.51 USD
7/13/20264.79 USD
7/10/20264.64 USD
7/9/20264.73 USD
7/8/20264.65 USD
7/7/20264.88 USD
7/6/20264.93 USD
7/2/20264.87 USD
7/1/20264.54 USD
6/30/20264.13 USD
6/29/20264.20 USD
6/26/20264.13 USD
6/25/20264.20 USD
6/24/20264.50 USD
6/23/20264.55 USD
6/22/20264.58 USD
6/18/20264.75 USD
6/17/20264.91 USD
6/16/20264.82 USD
6/15/20264.91 USD
6/12/20264.70 USD
6/11/20264.90 USD
6/10/20264.97 USD
6/9/20264.82 USD
6/8/20265.02 USD
6/5/20264.89 USD
6/4/20264.87 USD
6/3/20264.56 USD
6/2/20264.69 USD
6/1/20264.63 USD
5/29/20264.28 USD
5/28/20264.59 USD
5/27/20264.57 USD
5/26/20264.24 USD
5/22/20264.19 USD
5/21/20264.07 USD
5/20/20264.26 USD
5/19/20264.30 USD
5/18/20264.24 USD
5/15/20264.33 USD
5/14/20264.48 USD
5/13/20264.54 USD
5/12/20264.28 USD
5/11/20264.39 USD
5/8/20264.78 USD
5/7/20264.49 USD
5/6/20265.27 USD
5/5/20265.13 USD
5/4/20265.09 USD
5/1/20265.00 USD
4/30/20264.68 USD
4/29/20264.43 USD
4/28/20264.55 USD
4/27/20264.57 USD
4/24/20264.64 USD
4/23/20264.73 USD
4/22/20264.62 USD
4/21/20264.53 USD
4/20/20265.06 USD
4/17/20264.09 USD
4/16/20263.94 USD
4/15/20263.83 USD
4/14/20263.77 USD
4/13/20263.91 USD
4/10/20263.47 USD
4/9/20263.40 USD
4/8/20263.47 USD
4/7/20263.43 USD
4/6/20263.58 USD
4/2/20263.51 USD
4/1/20263.58 USD
3/31/20263.61 USD
3/30/20263.60 USD
3/27/20263.72 USD
3/26/20263.94 USD
3/25/20263.90 USD
3/24/20263.88 USD
3/23/20263.98 USD
3/20/20263.90 USD
3/19/20264.09 USD
3/18/20264.11 USD
3/17/20264.44 USD
3/16/20264.40 USD
3/13/20263.98 USD
3/12/20263.94 USD
3/11/20264.06 USD
3/10/20263.91 USD
3/9/20263.12 USD
3/6/20263.00 USD
3/5/20263.00 USD
3/4/20263.12 USD
3/3/20262.91 USD
3/2/20262.91 USD
2/27/20262.67 USD
2/26/20262.78 USD
2/25/20262.76 USD
2/24/20262.67 USD
2/23/20262.64 USD
2/20/20262.82 USD
2/19/20262.90 USD
2/18/20262.95 USD
2/17/20262.85 USD
2/13/20262.78 USD
2/12/20262.80 USD
2/11/20262.91 USD
2/10/20263.05 USD
2/9/20263.20 USD
2/6/20263.14 USD
2/5/20262.77 USD
2/4/20263.07 USD
2/3/20263.18 USD
2/2/20263.28 USD
1/30/20263.24 USD
1/29/20263.37 USD
1/28/20263.40 USD
1/27/20263.50 USD
1/26/20263.52 USD
1/23/20263.58 USD
1/22/20263.62 USD
1/21/20263.54 USD
1/20/20263.56 USD
1/16/20263.77 USD
1/15/20263.77 USD
1/14/20263.85 USD
1/13/20263.98 USD
1/12/20264.19 USD
1/9/20263.86 USD
1/8/20264.00 USD
1/7/20263.93 USD
1/6/20264.22 USD
1/5/20263.91 USD
1/2/20263.49 USD
12/31/20253.41 USD
12/30/20253.49 USD
12/29/20253.44 USD
12/26/20253.50 USD
12/24/20254.00 USD
12/23/20253.46 USD
12/22/20253.20 USD
12/19/20253.23 USD
12/18/20253.24 USD
12/17/20253.24 USD
12/16/20253.42 USD
12/15/20253.27 USD
12/12/20253.40 USD
12/11/20253.46 USD
12/10/20253.61 USD
12/9/20253.63 USD
12/8/20253.64 USD
12/5/20253.50 USD
12/4/20253.73 USD
12/3/20253.72 USD
12/2/20253.56 USD
12/1/20253.57 USD
11/28/20253.83 USD
11/26/20253.84 USD
11/25/20253.93 USD
11/24/20253.97 USD
11/21/20253.85 USD
11/20/20253.71 USD
11/19/20253.99 USD
11/18/20254.09 USD
11/17/20254.73 USD
11/14/20254.63 USD
11/13/20254.62 USD
11/12/20255.07 USD
11/11/20255.06 USD
11/10/20255.13 USD
11/7/20255.24 USD
11/6/20255.26 USD
11/5/20255.63 USD
11/4/20255.42 USD
11/3/20255.74 USD
10/31/20255.91 USD
10/30/20255.80 USD
10/29/20256.12 USD
10/28/20256.15 USD
10/27/20256.14 USD
10/24/20256.30 USD
10/23/20256.23 USD
10/22/20256.15 USD
10/21/20256.17 USD
10/20/20256.22 USD
10/17/20256.08 USD
10/16/20256.43 USD
10/15/20256.43 USD
10/14/20256.35 USD
10/13/20256.15 USD
10/10/20256.17 USD
10/9/20256.54 USD
10/8/20256.64 USD
10/7/20256.63 USD
10/6/20256.94 USD
10/3/20256.97 USD
10/2/20256.92 USD
10/1/20256.75 USD
9/30/20256.79 USD
9/29/20256.44 USD
9/26/20256.43 USD
9/25/20256.22 USD
9/24/20256.40 USD
9/23/20256.32 USD
9/22/20256.55 USD
9/19/20256.36 USD
9/18/20256.43 USD
9/17/20256.08 USD
9/16/20256.01 USD
9/15/20255.83 USD
9/12/20255.80 USD
9/11/20255.89 USD
9/10/20255.95 USD
9/9/20256.08 USD
9/8/20256.15 USD
9/5/20256.06 USD
9/4/20256.28 USD
9/3/20256.10 USD
9/2/20256.17 USD
8/29/20256.19 USD
8/28/20256.46 USD
8/27/20256.41 USD
8/26/20256.50 USD
8/25/20256.19 USD
8/22/20256.33 USD
8/21/20256.29 USD
8/20/20256.19 USD
8/19/20256.11 USD
8/18/20256.52 USD
8/15/20256.43 USD
8/14/20256.60 USD
8/13/20256.89 USD
8/12/20256.83 USD
8/11/20256.72 USD
8/8/20256.82 USD
8/7/20256.61 USD
8/6/20256.53 USD
8/5/202511.84 USD
8/4/202512.35 USD
8/1/20259.94 USD
7/31/202510.41 USD
7/30/202510.09 USD
7/29/202510.20 USD
7/28/202510.87 USD
7/25/202510.69 USD
7/24/202510.67 USD
7/23/202510.85 USD
7/22/202510.36 USD
Access this data via the Eulerpool API

LifeMD Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
92.90 M USD
-54.30 M USD
-61.80 M USD
Jan 1, 2022
119.00 M USD
-34.60 M USD
-48.60 M USD
Jan 1, 2023
152.55 M USD
-14.49 M USD
-23.70 M USD
Jan 1, 2024
212.45 M USD
-16.14 M USD
-21.99 M USD
Jan 1, 2025 (e)
241.45 M USD
-2.83 M USD
-10.12 M USD
Jan 1, 2026 (e)
228.51 M USD
-6.28 M USD
-3.07 M USD
Jan 1, 2027 (e)
268.87 M USD
4.18 M USD
11.13 M USD
Jan 1, 2028 (e)
237.56 M USD
4.08 M USD
-982,056.00 USD

LifeMD Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 22, 2026, 11:20 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2013201420152016201720182019202020212022202320242025e2026e2027e2028e
1.005.003.008.0012.0037.0092.00119.00152.00212.00241.00228.00268.00237.00
400.00-40.00166.6750.00208.33148.6529.3527.7339.4713.68-5.3917.54-11.57
100.0060.0066.6775.0075.0075.6880.4384.0387.5088.6888.6888.6888.6888.68
188.00188.001.003.002.006.009.0028.0074.00100.00133.00188.00213.72202.19237.66210.17
-1.00-1.00-2.00-2.00-57.00-54.00-34.00-14.00-16.00-2.00-6.004.004.00
-20.00-33.33-25.00-16.67-154.05-58.70-28.57-9.21-7.55-0.83-2.631.491.69
-1.00-1.00-1.00-3.00-63.00-61.00-48.00-23.00-21.00-10.00-3.0011.00
200.002,000.00-3.17-21.31-52.08-8.70-52.38-70.00-466.67
5.906.106.206.708.308.809.9014.3027.0031.0033.9141.2041.2041.2041.2041.20
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales LifeMD generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue LifeMD retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare LifeMD's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares LifeMD has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against LifeMD's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

LifeMD stock margins

The LifeMD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of LifeMD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for LifeMD.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
76.14 %
-154.96 %
-169.97 %
Jan 1, 2021
80.62 %
-58.45 %
-66.52 %
Jan 1, 2022
84.37 %
-29.08 %
-40.84 %
Jan 1, 2023
87.61 %
-9.50 %
-15.54 %
Jan 1, 2024
88.67 %
-7.60 %
-10.35 %
Jan 1, 2025 (e)
88.67 %
-1.17 %
-4.19 %
Jan 1, 2026 (e)
88.67 %
-2.75 %
-1.34 %
Jan 1, 2027 (e)
88.67 %
1.55 %
4.14 %

LifeMD Stock Revenue, EBIT, Earnings per Share

The LifeMD earnings per share therefore indicates how much revenue LifeMD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
2.61 USD
-4.04 USD
-4.43 USD
Jan 1, 2021
3.44 USD
-2.01 USD
-2.29 USD
Jan 1, 2022
3.84 USD
-1.12 USD
-1.57 USD
Jan 1, 2023
4.50 USD
-0.43 USD
-0.70 USD
Jan 1, 2024
5.16 USD
-0.39 USD
-0.53 USD
Jan 1, 2025 (e)
5.02 USD
-0.07 USD
-0.21 USD
Jan 1, 2026 (e)
4.75 USD
-0.15 USD
-0.06 USD
Jan 1, 2027 (e)
5.59 USD
0.10 USD
0.23 USD

LifeMD business model & stock analysis

LifeMD Inc. is an innovative company that specializes in providing affordable and high-quality healthcare products and services for people of all ages. The company was founded in 2020 and has since become a leading provider of telemedicine services and healthcare products in the USA. Its business model is based on the idea of offering a comprehensive range of healthcare services and products at an affordable price. The company utilizes the latest technologies in telemedicine to simplify and expedite the delivery of healthcare services. This allows patients to conveniently receive medical consultations from home without having to visit a doctor. LifeMD's various divisions include telemedicine, diagnostics, personal care, dietary supplements, and healthcare products. Each division is focused on meeting the individual needs and requirements of customers. Telemedicine is one of LifeMD's main divisions, allowing patients to receive medical consultations online without leaving their homes. The offerings include a variety of medical services such as consultations with doctors, online prescriptions, and home visits from certified nurses. LifeMD’s diagnostic division offers a wide range of diagnostic tests that can be easily conducted at home. The results are quickly and easily transmitted to the doctor, who then provides appropriate treatment recommendations. Under the personal care division, LifeMD offers a variety of products tailored to the needs of the skin and hair. The products are made from natural ingredients and are free from harmful chemicals. The range includes skincare products, hair care products, and personal care accessories. Another focus of LifeMD is dietary supplements aimed at improving physical well-being. The company has developed a range of high-quality dietary supplements tailored to the needs of people of all ages. This includes supplements for energy, digestion, the immune system, and more. In addition to the aforementioned divisions, LifeMD offers a variety of healthcare products, including fitness equipment, medical accessories such as blood pressure monitors or pulse oximeters, and detoxification products. Overall, LifeMD offers a wide range of healthcare products and services to improve the physical and mental well-being of its customers. The company aims to provide high-quality products and services at an affordable price to achieve maximum benefit for its customers.

LifeMD SWOT Analysis

Strengths

LifeMD Inc has a strong online presence, with a well-established brand and a large customer base. The company offers a wide range of telehealth services, which allows for convenient and accessible healthcare for patients. This provides a competitive edge in the market.

The company's proprietary technology platform enables seamless communication between healthcare providers and patients, enhancing the efficiency of consultations and ensuring personalized care.

LifeMD Inc has a team of highly skilled and experienced healthcare professionals who provide quality medical guidance and treatment to patients. This expertise contributes to the company's reputation as a trusted provider of telehealth services.

Weaknesses

One of the weaknesses of LifeMD Inc is its dependence on technology and internet connectivity. Any technical disruptions or network issues may hinder the delivery of telehealth services, resulting in potential dissatisfaction among customers.

The company's reliance on virtual consultations may limit the scope of physical examinations and diagnostic tests, which could affect the accuracy of diagnoses and treatment plans.

LifeMD Inc may face challenges in attracting and retaining healthcare professionals due to the remote nature of telehealth services. This may impact the availability and accessibility of medical expertise for patients.

Opportunities

The growing demand for telehealth services presents significant opportunities for LifeMD Inc to expand its customer base and increase revenue. The convenience and cost-effectiveness of remote consultations appeal to patients seeking quick and hassle-free healthcare solutions.

LifeMD Inc has the potential to tap into underserved markets or areas with limited access to traditional healthcare facilities. By providing telehealth services, the company can bridge the healthcare gap and reach individuals living in remote or rural locations.

The advancement of technology and increasing acceptance of virtual healthcare consultations in the medical industry create a favorable environment for the growth and development of LifeMD Inc's telehealth services.

Threats

LifeMD Inc faces competition from other telehealth providers in the market. This requires continuous innovation and differentiation to stand out and maintain a competitive advantage.

Regulatory changes and limitations imposed on telehealth services could impact the operations and profitability of LifeMD Inc. Complying with evolving healthcare laws and regulations is crucial to ensure continued legal operation.

Cybersecurity threats and data privacy concerns pose risks to LifeMD Inc and its customers. Protecting sensitive patient information and maintaining secure digital platforms are priorities to maintain trust and credibility.

LifeMD Segments

LifeMD Revenue by Segment (1/3)

  • 3 Years

  • Max

Telehealth
Work simpli
Details
Date
Telehealth
Work simpli
Software Revenues, Net
Product Revenues, Net
Service Revenues, Net
Jan 1, 2021
68.20 M USD
24.68 M USD
0.00 USD
0.00 USD
0.00 USD

LifeMD Revenue by Segment (2/3)

  • 3 Years

  • Max

Product
Details
Date
Product
Software Revenue
Jan 1, 2021
24.68 M USD
0.00 USD

LifeMD Revenue by Segment (3/3)

  • 3 Years

  • Max

Telehealth
Work simpli
Details
Date
Telehealth
Work simpli
Jan 1, 2021
68.20 M USD
24.68 M USD

LifeMD Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

LifeMD historical P/E ratio, EBIT multiple, and P/S ratio

LifeMD annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

LifeMD shares outstanding

The number of shares of LifeMD was 41.2 M in 2025. This indicates how many shares LifeMD is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
14.30 M Stocks
Jan 1, 2021
27.00 M Stocks
Jan 1, 2022
31.00 M Stocks
Jan 1, 2023
33.91 M Stocks
Jan 1, 2024
41.20 M Stocks
Jan 1, 2025 (e)
41.20 M Stocks
Jan 1, 2026 (e)
41.20 M Stocks
Jan 1, 2027 (e)
41.20 M Stocks

LifeMD stock splits

In LifeMD's history, there have been no stock splits.

Current LifeMD forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy85.71 % (12)
Hold14.29 % (2)
Sell0.00 % (0)
12M Price Target
8.67
Last Price
4.32
Currency
USD
12M Return Potential
100.69 %
LTM Return
0 %

LifeMD Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/6/2026-0.15USD50.14 MUSD2026 Q2
8/3/2026-0.15USD50.14 MUSD2026 Q2
5/8/2026-0.23USD49.82 MUSD2026 Q1
5/4/2026-0.23USD49.82 MUSD2026 Q1
3/16/2026-0.03USD49.54 MUSD2025 Q4
3/9/2026-0.03USD49.54 MUSD2025 Q4
11/17/2025-0.05USD63.31 MUSD2025 Q3
11/6/2024-0.06USD49.62 MUSD2024 Q3
5/10/2024-0.13USD43.14 MUSD2024 Q1
3/20/2024-0.14USD41.23 MUSD2023 Q4

EESG©

Eulerpool ESG Scorecard© for the LifeMD stock

10/100
3
Environment
4
Social
22
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

LifeMD shareholder structure

% Name
5.92795%
Schreiber (Justin)
Schreiber (Justin)
5.00443%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
4.33345%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
3.70845%
Galluppi (Stefan)
Galluppi (Stefan)
2.53387%
D. E. Shaw & Co., L.P.
D. E. Shaw & Co., L.P.
2.36590%
Nuveen LLC
Nuveen LLC
...

LifeMD Executives and Management Board

MB

Mr. Marc Benathen

(45)

Chief Financial Officer

Compensation2.60 M USD
NA

Mr. Nicholas Alvarez

(33)

Chief Acquisition Officer

Compensation1.64 M USD
SG

Mr. Stefan Galluppi

(38)

Chief Innovation Officer · since 2017

Compensation1.60 M USD
DW

Mr. Dennis Wijnker

(49)

Chief Technology Officer

Compensation1.31 M USD
WF

Mr. William Febbo

(56)

Director

Compensation1.16 M USD

Frequently asked questions about LifeMD

LifeMD Inc is a leading telehealth company that focuses on providing customized and convenient healthcare solutions to its customers. The business model of LifeMD Inc revolves around offering telemedicine consultations, prescription medications, and direct-to-consumer laboratory testing services. By leveraging advanced technology and a team of experienced healthcare professionals, LifeMD Inc aims to improve access to high-quality healthcare for individuals seeking personalized treatment options.

All fundamentals and in-depth analysis of LifeMD

Our stock analysis for LifeMD stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LifeMD. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.